To do so, co-IP of tau aggregates using T18 antibody was performed from PBS-insoluble fractions of AD brain homogenates in addition to PBS-soluble fractions containing oligomeric tau and higher-order tau aggregates, respectively. Here, MAPT is linked to Alzheimer disease.